Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
DCPH | A | Deciphera Pharmaceuticals, Inc. | 0.08 | |
FUSN | A | Fusion Pharmaceuticals Inc. | 0.05 | |
LDOS | A | Leidos Holdings, Inc. | 0.04 | |
REGN | B | Regeneron Pharmaceuticals, Inc. | 0.18 | |
GMED | B | Globus Medical, Inc. | -1.65 | |
MACK | B | Merrimack Pharmaceuticals, Inc. | 0.26 | |
NVAX | B | Novavax, Inc. | 0.00 | |
CRVO | B | CervoMed Inc. | 0.20 | |
NKTR | B | Nektar Therapeutics | -0.29 | |
AXSM | B | Axsome Therapeutics, Inc. | 1.08 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IBB | C | iShares Nasdaq Biotechnology Index Fund | 9.02 | |
IBBQ | B | Invesco Nasdaq Biotechnology ETF | 8.99 | |
BBH | B | Market Vectors Biotech ETF | 7.93 | |
BBP | B | BioShares Biotechnology Products Fund | 7.3 | |
IDNA | B | iShares Genomics Immunology and Healthcare ETF | 6.35 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles